Related Experiment Videos

The Beckwith-Wiedemann syndrome in four African infants

Insights

Beckwith-Wiedemann syndrome, a rare genetic overgrowth disorder, presents risks of malignancy and hypoglycemia. Early diagnosis and recognition are crucial for managing affected infants and improving outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Genetics
  • Developmental Biology

Background:

  • Beckwith-Wiedemann syndrome (BWS) is a congenital overgrowth disorder.
  • It is associated with an increased risk of certain childhood cancers and metabolic disturbances.
  • Understanding its diverse clinical manifestations is essential for timely intervention.

Purpose of the Study:

  • To report four cases of Beckwith-Wiedemann syndrome.
  • To review the syndrome's clinical, pathological, radiological, and laboratory findings.
  • To emphasize the importance of early diagnosis and management, particularly regarding malignancy risk and hypoglycemia.

Main Methods:

  • Case series reporting four patients with BWS.
  • Comprehensive review of clinical data, pathology, radiology, and laboratory results.
  • Literature review on BWS management and outcomes.

Main Results:

  • Detailed findings from four BWS cases are presented.
  • The study highlights the significant risk of intra-abdominal malignancy in both complete and incomplete BWS forms.
  • Early detection of hypoglycemia in infants with omphalocele is critical.

Conclusions:

  • Early diagnosis of Beckwith-Wiedemann syndrome is paramount due to associated risks.
  • Vigilance for intra-abdominal malignancy and prompt management of hypoglycemia are crucial.
  • Findings suggest potential hyperresponsiveness of insulin secretion to intravenous glucose in some cases.

Related Concept Videos